Innovating Works

EUROPESE FEDERATIE VAN CROHN EN COLITIS...

Desconocido
FIBROTARGET: Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases EUROPEAN FEDERATION OF CROHNS AND ULCERATIVE COLITIS ASSOCIATIONS participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Fibrostenosis is the driving reason for the persistent need in bowel resections in inflammatory bowel diseases (IBD). Current IBD therapies...
2023-04-24 - 2028-03-31 | Financiado
METHYLOMIC: DNA methylation markers to predict treatment success of biologicals in Crohn’s disease. EUROPEAN FEDERATION OF CROHNS AND ULCERATIVE COLITIS ASSOCIATIONS participó en un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11 Monoclonal antibodies have become a mainstay of therapy in common immune-mediated diseases (IMID) including Crohn’s disease (CD), rheumatoid...
2022-11-24 - 2026-12-31 | Financiado
GENEGUT: Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease EUROPEAN FEDERATION OF CROHNS AND ULCERATIVE COLITIS ASSOCIATIONS participó en un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 Crohn’s disease is a non-communicable, global disease with an accelerating incidence (up to 23 per 100,000 persons/year) and annual health c...
2022-05-19 - 2026-09-30 | Financiado
IDEA-FAST: Identifying Digital Endpoints to Assess FAtigue Sleep and acTivities in daily living in Neurodegene... EUROPEAN FEDERATION OF CROHNS AND ULCERATIVE COLITIS ASSOCIATIONS participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage Fatigue and sleep disturbances are two common and disabling symptoms that affect patients with neurodegenerative disorders (NDD) and immune-...
2019-12-18 - 2026-04-30 | Financiado
ImmUniverse: Better control and treatment of immune mediated diseases by exploring the universe of microenvironme... EUROPEAN FEDERATION OF CROHNS AND ULCERATIVE COLITIS ASSOCIATIONS participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage Immune-mediated diseases (IMIDs) are an increasing medical burden in industrialized countries worldwide. IMIDs are characterized by an enorm...
2019-12-17 - 2024-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.